Increased knee muscle strength is associated with decreased activity limitations in established knee osteoarthritis: Two-year follow-up study in the Amsterdam Osteoarthritis cohort by Sanchez Ramirez, D.C. et al.
VU Research Portal
Increased knee muscle strength is associated with decreased activity limitations in
established knee osteoarthritis: Two-year follow-up study in the Amsterdam
Osteoarthritis cohort
Sanchez Ramirez, D.C.; van der Leeden, M.; van der Esch, M.; Roorda, L.D.;
Verschueren, S.; van Dieen, J.H.; Lems, W.F.; Dekker, J.
published in
Journal of Rehabilitation Medicine
2015
DOI (link to publisher)
10.2340/16501977-1973
Link to publication in VU Research Portal
citation for published version (APA)
Sanchez Ramirez, D. C., van der Leeden, M., van der Esch, M., Roorda, L. D., Verschueren, S., van Dieen, J.
H., Lems, W. F., & Dekker, J. (2015). Increased knee muscle strength is associated with decreased activity
limitations in established knee osteoarthritis: Two-year follow-up study in the Amsterdam Osteoarthritis cohort.
Journal of Rehabilitation Medicine, 47(7), 647-654. https://doi.org/10.2340/16501977-1973
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
E-mail address:
vuresearchportal.ub@vu.nl
Download date: 14. Sep. 2021
ORIGINAL REPORT
J Rehabil Med 2015 Preview
J Rehabil Med 47© 2015 The Authors. doi: 10.2340/16501977-1973
Journal Compilation © 2015 Foundation of Rehabilitation Information. ISSN 1650-1977
Objective: To examine the association between changes in 
knee muscle strength (extensor and flexor muscles separate-
ly, and mean values) and changes in activity limitations in 
patients with established knee osteoarthritis at 2 years.
Methods: Data from 186 patients with knee osteoarthritis, 
part of the Amsterdam Osteoarthritis cohort, were gathered 
at baseline and at 2-year follow-up. Strength of the knee ex-
tensor and flexor muscles were assessed using an isokinetic 
dynamometer. Activity limitations were assessed using the 
Western Ontario and McMaster University Osteoarthritis 
Index (WOMAC) – Physical Function subscale, the Get Up 
and Go test (GUG), and the 12-steps stairs test. Univariate 
and multivariate linear regression analyses were used to as-
sess the association between changes in muscle strength and 
changes in activity limitations, adjusting for relevant con-
founders and baseline activity limitations. 
Results: There was an overall 16% increase in mean knee 
muscle strength (p < 0.001), 19% increase in knee extensor 
muscle strength (p < 0.001), and 17% increase in knee flexor 
muscle strength (p < 0.001) at 2 years. Increased mean knee 
muscle strength and knee flexor muscle strength were associ-
ated with better self-reported physical function (WOMAC) 
(b = –5.7, p = 0.03 and b = –6.2, p = 0.05), decreased time on 
the GUG (b = –1.2, p = 0.003 and b = –1.4, p = 0.05) and de-
creased time on the stairs test (b = –4.4, p < 0.001 and b = –6.6, 
p < 0.001). Increased extensor muscle strength was associ-
ated only with decreased time on the stairs test (b = –2.7, 
p < 0.001).
Conclusion: Increased knee muscle strength, mainly in the 
knee flexors, was associated with decreased activity limita-
tions in patients with knee osteoarthritis at 2 years. Thus, 
differences in muscle strength may partially explain the be-
tween-patients variability in activity limitations.
Key words: knee osteoarthritis; muscle strength; activity limita-
tions.
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INTRODUCTION
Osteoarthritis (OA), the most common form of arthritis affect-
ing the synovial joints, is considered a major cause of pain 
and activity limitations (1). Activity limitations are defined as 
difficulties in performing daily activities (2). Previous studies 
have shown a slow increase in activity limitations over time in 
patients with OA (3), while others have found no change, or 
even a decrease in activity limitations in this group of patients 
(4, 5). Nevertheless, there is high between-patients variability 
in the course of activity limitations in patients with OA, which 
requires further explanation (6, 7).
Muscle strength is considered a relevant determinant of 
activity limitations in patients with knee OA (5). The cross-
sectional relationship between low muscle strength and activity 
limitations has been reported extensively (5, 8). Moreover, 
earlier studies have shown baseline muscle strength in patients 
with OA as a potential predictor for activity limitations in the 
long term (4, 6, 9, 10). The longitudinal association between 
a decrease in muscle strength and an increase in activity 
limitations has been studied in 2 observational studies, with 
conflicting results (4, 11), and in one clinical trial, which 
failed to control for relevant confounders (12). Overall, there 
is scarce evidence about the longitudinal association between 
muscle strength and activity limitations, in the absence of a 
well-defined intervention, in patients with established knee OA. 
Testing the longitudinal association between muscle strength 
and activity limitations in knee OA is a direct and necessary 
extension beyond cross-sectional research in this area.
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Previous studies have focused mainly on the association of 
knee extensor muscle strength and activity limitations. There 
has been little research into the role of knee flexor muscle 
strength in activity limitations in patients with OA. However, 
in this group of patients an appropriate strength of the knee 
extensor and flexor muscles is important for stability of the 
knee and prevention of joint stress (13). 
The aim of this study is to examine the association between 
changes in knee muscle strength (extensor and flexor muscles 
separately, and averaged) and changes in activity limitations in 
patients with established knee OA at 2 years. We hypothesized 
that, in patients with established OA, an increase in strength 
of the knee extensor and flexor muscles, as well as an increase 
in mean knee muscle strength, would be associated with a 
decrease in activity limitations in the long term. 
PATIENTS AND METHODS
Patients
A total of 186 patients from the Amsterdam Osteoarthritis (AMS-OA) 
cohort (127 females, 59 males) with unilateral or bilateral diagnosis of 
knee OA according to the American College of Rheumatology (ACR) 
criteria (15) were included in this study. The AMS-OA is a cohort of 
patients with OA of the knee and/or hip (16, 17), who have been referred 
to an outpatient rehabilitation centre (Reade, Centre for Rehabilitation 
and Rheumatology, Amsterdam, The Netherlands) (14, 18). In the present 
study, the group of patients was defined as established knee OA due to 
the combination of confirmed diagnosis of knee OA according to ACR 
criteria and the presence of OA-related problems that led patients to seek 
specialized care. Patients were assessed by rheumatologists, radiologists 
and rehabilitation physicians. Exclusion criteria were rheumatoid arthri-
tis or any other form of inflammatory arthritis (i.e. crystal arthropathy, 
septic arthritis, spondyloarthropathy), and total knee replacement during 
the follow-up period. Two years after the baseline assessment patients 
were invited to the follow-up assessment (Fig. 1) . Demographic, radio-
graphic, clinical, psychosocial and biomechanical factors related to OA 
were assessed at baseline and at 2-year follow-up. The assessment of 
muscle strength and physical performance was completed by the same 
2 trained movement scientists following an established and approved 
protocol. At follow-up, the data collectors did not have information on 
baseline assessment. Only patients who completed the assessment at 
both time-points were included in the study. All patients provided written 
inform consent according to the Declaration of Helsinki. The study was 
approved by the Reade Institutional Review Board. 
Measures
Muscle strength. Knee muscle strength was assessed concentrically 
using an isokinetic dynamometer (EnKnee, Enraf-Nonius, Rotterdam, 
Netherlands) at baseline and at 2-year follow-up (18). Patients carried 
out an initial practice attempt to familiarize them with the required 
movements. The patients performed 3 maximal test repetitions to 
measure the isokinetic strength of the knee extensor muscles (mainly 
quadriceps) and knee flexor muscles (mainly hamstrings) for each 
knee, at 60°/s. The mean values of knee muscle strength (knee extensor 
and flexor combined, as well as mean knee extensor and mean flexor 
muscle strength (separate) per leg were calculated (Nm) and divided 
by the patient’s weight (kg) (19). This measure (in Nm/kg) has shown 
an excellent intra-rater reliability (intraclass correlation coefficient 
(ICC) 0.93) in patients with knee OA (20). Muscle strength parameters 
were averaged over the 2 legs, due to the fact that 132 (71%) patients 
included in the study had OA in both knees and muscle strength in 
the 2 legs was highly correlated in our group of patients (r = 0.82, 
p = 0.01). In addition, optimal muscle strength in both legs is required 
for an appropriate performance of ambulatory activities of daily living.
Activity limitations. Activity limitations were assessed using the Western 
Ontario and McMaster Universities Osteoarthritis physical function in-
dex subscale (WOMAC-PF), a self-reported questionnaire, and 2 physi-
cal performance tests (the Get Up and Go test (GUG) and the stairs test).
The WOMAC questionnaire was used to evaluate self-reported 
activity limitations, stiffness and pain in patients with OA (21). It has 
5 items related to pain and 2 related to stiffness. The physical function 
(PF) section comprises 17 items, each scored 0–4, giving a possible 
total score of 0–68. Higher scores represent more activity limitations. 
A validated Dutch version of WOMAC (22) was used in this study. 
The GUG test (23, 24) was performed with patients sitting on a high 
standard chair (seat height 49 cm). Patients were instructed to stand 
up without the help of the arms on the command “go”, and walk 15 m 
along an unobstructed corridor as quickly as possible, without running. 
The chronometer was stopped when they reached a mark on the floor. 
All patients were wearing walking shoes. Patients who normally used 
walking devices were allowed to use them during the test. A longer time 
(s) taken to perform the test was considered a greater activity limitation. 
In the stairs test (18), patients were instructed to climb 12 stairs (16 
cm high), 1 stair at a time, as fast as possible, without running. Patients 
were encouraged not to use the handrail, but were not prohibited from 
doing so for safety. Once they reached the top, the chronometer was 
stopped while they turned around. Subsequently and following the 
same instructions, after a signal, the chronometer started again while 
the subjected descended the stairs. Both times (in s) were recorded 
independently and then added to calculate the time for the whole 
task. All patients were wearing comfortable walking shoes. A longer 
time performing the test was considered a higher activity limitation. 
Potential confounders. Demographic data (i.e. age and gender) were 
recorded. Information related to comorbidities was collected with the 
Cumulative Illness Rating Scale (CIRS) (25). This instrument allows 
information to be gathered related to 13 body systems, scoring from 0 
(none) to 4 (extremely severe) according to the severity of the condition. 
The number of diseases on which the patients scored a severity of 2 
or higher was calculated and incorporated in the analyses. Body mass 
index (BMI) was calculated as body mass in kg divided by height in m2 
Fig. 1. Patients course during the study.
Patients at two years follow-up
n=186 (75%)
Patients with knee OA at baseline 
ACR criteria
n=268
Excluded due to Total Knee Replacement 
during the follow-up period
n=21 (8%)
Patients with knee OA at baseline 
ACR criteria
n=247
Did not participated in the follow-up 
assessment n=61 (25%)
No longer interested/distance n=30
Personal/family reasons n=3
Health complaints n=10
Insurance/own risk payment n=6
Patient could not be reached/unknown 
reason n=12
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(kg/m2). C-reactive protein (CRP) (mg/l) levels were measured in serum 
from patients’ blood samples and processed immunoturbidimetrically 
using CRPLX test kits (26–28) and the Roche Cobas-6000 analyser. 
Non-steroidal anti-inflammatory drug (NSAID) use was dichotomized 
(yes/no). Pain level was assessed using the WOMAC pain subscale 
(21). In addition, at 2-year follow-up the patients were asked if they 
had received physiotherapy at any institution or if they took part in a 
study involving physical therapy intervention during the past 2 years.
Statistical analysis
Descriptive statistics were used to characterize the study population at 
baseline and at 2-year follow-up. Percentages were used for categorical 
variables, medians (interquartile ranges (IQRs)) and means (standard 
deviations (SDs)) for continuous variables. McNemar tests and paired 
t-tests were used to analyse the differences in the distribution of the 
variables at baseline and at 2-year follow-up.
The baseline to 2-year follow-up change score was calculated for 
knee muscle strength (extensor and flexor muscles separately, and aver-
aged) and activity limitations (WOMAC-PF, GUG and stairs test). The 
association between change in muscle strength (Nm/kg) and change in 
activity limitations was analysed using linear regression (analysis of 
covariance) (29). First, regression analyses were used to explore the 
association between change in muscle strength and change in activity 
limitations at 2-year follow-up, adjusting for baseline activity limitations 
(crude models) (29). Secondly, relevant confounding was defined as 10% 
change in the crude regression coefficient of the central determinant, 
after adjustment for an additional variable (30). The confounding effect 
of other variables possibly affecting the association between muscle 
strength and activity limitations (i.e. age, gender, change in comorbidi-
ties, change in NSAID use, change in BMI, change in CRP levels, change 
in WOMAC pain and physical therapy treatment) was evaluated based 
on a 10% difference between crude and adjusted regression coefficient. 
Thirdly, fully adjusted multivariable regression models including all 
relevant confounding variables were analysed.
Statistical significance was accepted at p-values < 0.05. All analyses 




A total of 268 patients with knee OA who completed the baseline 
assessment were invited to participate in the follow-up evaluation. 
Eight percent (n = 21) of the patients were excluded from the study 
due to total knee replacement. From the eligible patients who met 
the inclusion criteria at follow-up (n = 247), 25% (n = 61) declined 
the invitation for various reasons. Fig. 1 shows the patient flow 
during the study. There were no significant differences in baseline 
characteristics between the groups of patients who were and were 
not part of the 2-year follow-up assessment (Table I). 
Descriptives
Demographic and clinical characteristics of the patients who par-
ticipated at baseline and at 2-year follow-up (n = 186) are shown 
in Table II. Sixty-eight percent of the study group (n = 127) were 
women. Mean age at baseline was 61 years (SD 7.3). In the 
study group, there was an overall 16% increase in mean knee 
muscle strength mean (0.08 Nm/kg (SD 0.2); p < 0.001), 19% 
increase in knee extensor muscle strength (0.11 Nm/kg (SD 
0.3); p < 0.001) and 17% increase in knee flexor muscle strength 
(0.06 Nm/kg (SD 0.2); p < 0.001) at 2 years. At the follow-up 
assessment, the time for completing the stairs test decreased in 
the study group (p = 0.039) and there was a borderline significant 
decrease in WOMAC-PF score (p = 0.053). However, there was 
no statistically significant change in mean time for completing 
the GUG test (p = 0.871) at 2 years.
Associations between changes in muscle strength and changes 
in activity limitations at 2 years
Tables III–V show the crude associations between change in knee 
muscle strength and change in activity limitations at 2 years. 
Increases in mean knee muscle strength and knee flexor muscle 
strength were significantly associated with a decrease in WOM-
AC-PF score, and a decrease in time (s) performing the GUG and 
the stairs test. After the addition of 1 possible confounder at the 
time to the crude models, comorbidities change, NSAIDs change 
and WOMAC pain change were identified as relevant confounders 
(i.e. more than 10% change in the crude model regression coef-
ficient for the change in muscle strength). In the multivariable 
model, adjusted for all relevant confounders, increases in mean 
knee muscle strength and knee flexor muscle strength were still 
strongly associated with a decrease in WOMAC-PF score, and a 
decrease in time performing the GUG and the stairs test. In the 
crude models, an increase in knee extensor muscle strength was 
significantly associated with a decrease in WOMAC-PF score and 
a decrease in time performing the stairs test. However, in the fully 
adjusted models, increase in knee extensor muscle strength was 
only associated with a decrease in time performing the stairs test. 
Possible effect of physical therapy
Additional analysis revealed that the association between in-
crease in muscle strength and decrease in activity limitations 







Age, years, mean (SD) 61 (7.3) 62 (8.6)
Radiographic OA K/L score ≥ 2, n (%) 131 (71) 44 (73)
BMI, kg/m², mean (SD) 29.3 (5.6) 28.8 (4.6)
CRP, mg/l, mean (SD) 3.4 (5.4) 2.5 (2.2)
Comorbidities count (CIRS ≥ 2), mean (SD) 0.8 (0.9) 0.6 (0.9)
NSAIDs (yes), n (%) 33 (18) 7 (12)
Knee muscle strength, Nm/kg, mean (SD)a 0.91 (0.4) 0.96 (0.4)
Knee extensor muscle strength, Nm/kg, 
mean (SD) 1.08 (0.4 1.15 (0.5)
Knee flexor muscle strength, Nm/kg,  
mean (SD) 0.73 (0.3) 0.78 (0.3)
WOMAC pain score (0–20), mean (SD) 7.9 (3.8) 7.9 (3.0)
WOMAC stiffness score (0–8), mean (SD) 3.7 (1.7) 4.1 (1.5)
WOMAC physical function score (0–68), 
mean (SD) 28.6 (13.4) 29.8 (11.4)
GUG, s, mean (SD) 11.1 (3.8) 10.8 (2.3)
Stairs test, s, mean (SD) 9.1 (3.5) 9.4 (5.9)
aMean knee extensor and flexor muscle strength. Baseline characteristics 
were not significantly different between subgroups. 
OA: osteoarthritis; K/L: Kellgren/Lawrence; SD: standard deviation; 
CIRS: Cumulative Illness Rating Scale; NSAIDs: non-steroidal 
anti-inflammatory drugs; WOMAC: Webster Ontario and McMaster 
Osteoarthritis index; GUG: Get Up and Go test. 
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Table III. Association between knee muscle strength change and changes in activity limitations over 2 years
WOMAC-PF score (0–68) GUG test (s) Stairs test (s)
b 95% CI p-value b 95% CI p-value b 95% CI p-value
1 Crude Model
KMS change –9.5 –16.7, –2.3 0.01 –1.8 –3.0, –0.5 0.01 –4.4 –6.5, –2.3 < 0.001
2 Adjusted Models
KMS change
+ gender –9.4 –16.6, –2.2 0.01 –1.7 –2.9, –0.5 0.01 –4.4 –6.5, –2.3 < 0.001
KMS change
+ age –9.2 –16.3, –2.2 0.01 –1.8 –3.0, –0.6 0.004 –4.4 –6.5, –2.3 < 0.001
KMS change
+ BMI change –9.1 –16.3, –1.9 0.01 –1.8 –3.0, –0.5 0.01 –4.4 –6.5, –2.3 < 0.001
KMS change
+ CRP change –9.3 –16.5, –2.0 0.01 –1.7 –3.0, –0.5 0.01 –4.3 –6.5, –2.2 < 0.001
KMS change
+ comorbidities change –9.4 –17.0, –1.9 0.01 –1.4* –2.5, –0.3 0.01 –4.2 –6.5, –2.0 < 0.001
KMS change
+ NSAIDs change –9.1 –16.3, –1.9 0.01 –1.6* –2.8, –0.4 0.01 –4.4 –6.5, –2.3 < 0.001
KMS change
+ WOMAC pain change –5.7* –10.9, –0.5 0.03 –1.5* –2.5, –0.4 0.01 –4.2 –6.2, –2.2 < 0.001
KMS change
+ PT treatment –9.3 –16.7, –2.0 0.01 –1.7 –3.0, –0.5 0.01 –4.3 –6.4, –2.2 < 0.001
3 Fully Adjusted
Model
KMS change –5.7B1 –10.9, –0.5 0.03 –1.2B2 –2.3, –0.1 0.03 –4.4B3 –6.5, –2.3 < 0.001
Linear regression analysis using change in knee muscle strength (KMS) (mean extensor and flexor) as independent factor. Changes in WOMAC-PF 
(Webster Ontario and McMaster Osteoarthritis index – Physical Function), Get Up and Go test (GUG), time walking up and down a lap of 12 stairs 
as dependent variables. 
b: regression coefficient; CI: confidence interval; CRP: C-reactive protein; NSAIDs: non-steroidal anti-inflammatory drugs; PT: physiotherapy. All 
models were adjusted for baseline activity limitations (analysis of covariance). 
*Factor affects the coefficient 10% or more. Reduce patient numbers in the multivariate linear regression analyses due to random data missing in the 
outcome measure or selected variables.
1: Crude Model; 2: Adjusted Model for relevant confounders; 3: Full Adjusted Model for factors affecting the crude coefficient 10% or more: B1Adjusted 
for WOMAC pain change and baseline WOMAC-PF; B2Adjusted for comorbidities change, NSAIDS change, WOMAC pain change and baseline 
GUG test; B3Adjusted for baseline stairs test. 
Table II. Characteristics of the study population (n = 186) 
Baseline Two-year follow-up
pn n
Age, years, mean (SD) 186 61 (7.3) – – –
Female, n (%) 186 127 (68) – – –
Radiographic OA, K/L score ≥ 2, n (%) 184 130 (70) 186 123 (66) 0.13
K/L score 2 58 (31) 55 (29)
K/L score 3 52 (28) 31 (17)
K/L score 4 20 (11) 37 (20)
BMI, kg/m2, mean (SD) 185 29.3 (5.5) 186 29.3 (5.4) 0.26
Comorbidities count (CIRS ≥ 2), mean (SD) 184 0.8 (1.0) 175 1.1 (1.0) 0.00
NSAIDs (yes), n (%) 185 30 (16) 186 38 (20) 0.23
CRP, mg/l, mean (SD) 183 3.4 (5.4) 184 2.9 (3.1) 0.21
Knee muscle strength, Nm/kg, mean (SD)a 177 0.92 (0.4) 183 0.98 (0.4) 0.00
Knee extensor muscle strength, Nm/kg, mean (SD) 179 1.1 (0.5) 185 1.2 (0.5) 0.00
Knee flexor muscle strength, Nm/kg, mean (SD) 181 0.7 (0.3) 184 0.8 (0.3) 0.00
WOMAC pain score (0–20), mean (SD) 183 7.9 (3.8) 185 7.0 (4.3) 0.01
WOMAC stiffness score (0–8), mean (SD) 179 3.7 (1.7) 186 3.5 (2.0) 0.02
WOMAC physical function score (0–68), mean (SD) 183 28.6 (13.4) 186 27.0 (15.3) 0.05
GUG, s, mean (SD) 185 11.0 (3.6) 185 10.9 (5.0) 0.87
Stairs test, s, mean (SD) 185 15.1 (8.8) 181 13.7 (7.3) 0.04
PT treatment during the past 2 years (yes), n (%) – No 
information
186 149 (80) –
aMean knee extensor and flexor muscle strength. 
OA: osteoarthritis; K/L: Kellgren/Lawrence, CRP: C-reactive protein, PT: physiotherapy; SD: standard deviation; CIRS: Cumulative Illness Rating 
Scale; NSAIDs: non-steroidal anti-inflammatory drugs; WOMAC: Webster Ontario and McMaster Osteoarthritis index; GUG: Get Up and Go test; 
BMI: body mass index. 
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occurred among those subjects who had received physical 
therapy interventions, and not among subjects who did not 
receive physical therapy (Table VI).
DISCUSSION
This study showed an association between increase in muscle 
strength and a decrease in activity limitations in patients with 
established knee OA at 2 years. This association suggests that 
muscle strength may partially explain the between-patients 
variability in the course of activity limitations. To the best 
of our knowledge, and based on a thorough review of the 
literature, this is the first observational study to describe the 
longitudinal association between knee muscle strength (exten-
sor and flexor muscles separately, and averaged) and activity 
limitations in patients with established knee OA.
This study represents an extension of evidence from previ-
ous cross-sectional, prediction models and intervention studies 
(4–6, 9, 10, 12), which have previously reported an associa-
tion between knee muscle strength and activity limitations. 
The additional value of the current observational study is the 
longitudinal association between knee extensor and flexor 
muscles strength separately, as well as mean knee muscle 
strength, with activity limitations in patients with established 
knee OA. A longitudinal association was found for increases in 
mean knee muscle strength and in knee flexor muscles strength, 
and a decrease in all the measures of activity limitations as-
sessed. However, increase in knee extensor muscle strength 
was associated only with a decrease in the stairs tests, which 
is a highly demanding performance activity. Moreover, the 
overall association found in the present study was confirmed 
in another longitudinal study carried out by our research group 
in patients with early OA (31).
Eighty percent of the study population reported having 
received some type of physical therapy intervention during 
the 2-year follow-up. This could explain the overall increase 
in muscle strength and decrease in activity limitations in the 
study group at 2 years. This interpretation is in line with the 
observation that the association between increase in muscle 
strength and decrease in activity limitations was limited to 
those subjects who had received physical therapy interven-
tions. Previous evidence has suggested that muscle weakness 
may precede activity limitations in patients with knee OA (7, 
10); with improvement seen after muscle strengthening inter-
ventions (32–36). The linear relationship between increased 
muscle strength and decreased activity limitations might be 
Table IV. Association between knee extensor muscle strength change and changes in activity limitations over 2 years
WOMAC-PF score (0–68) GUG test (s) Stairs test (s)
b 95% CI p-value b 95% CI p-value b 95% CI p-value
1 Crude Model
Knee extensor muscle strength 
(EMS) change




–6.0 –11.2, –0.7 0.03 –1.0* –2.0, 0.1 0.07 –2.7 –4.2, –1.1 0.001
EMS change
+ age
–5.9 –11.1, –0.7 0.03 –0.9 –2.0, 0.1 0.08 –2.7 –4.2, –1.1 0.001
EMS change
+ BMI change
–5.7 –11.0, –0.4 0.03 –0.9 –1.9, 0.2 0.10 –2.6 –4.2, –1.1 0.001
EMS change
+ CRP change
–5.1* –10.5, 0.3 0.06 –0.8* –1.9, 0.3 0.15 –2.7 –4.3, –1.1 0.001
EMS change
+ comorbidities change
–5.6 –11.0, –0.2 0.04 –0.9 –1.9, 0.1 0.09 –2.6 –4.2, –1.0 0.002
EMS change
+ NSAIDs change
–5.7 –11.0, –0.4 0.03 –0.9 –1.9, 0.2 0.10 –2.7 –4.2, –1.1 0.001
EMS change
+ WOMAC pain change
–3.8* –7.5, 0.01 0.05 –0.9 –2.0, 0.1 0.07 –2.6 –4.1, –1.1 0.001
EMS change
+ PT treatment
–5.8 –11.1, –0.4 0.04 –0.9 –2.0, 0.1 0.09 –2.6 –4.1, –1.0 0.001
3 Fully Adjusted
Model
EMS change –2.8B1 –6.6, 1.0 0.15 –0.8B2 –1.9, 0.2 0.12 –2.7B3 –4.2, –1.1 0.001
Linear regression analysis using change in knee extensor muscle strength as independent factor. Changes in WOMAC-PF (Webster Ontario and 
McMaster Osteoarthritis index-Physical Function), Get Up and Go test (GUG), time walking up and down a lap of 12 stairs as dependent variables. 
b: regression coefficient; CI: confidence interval; CRP: C-reactive protein; NSAIDs: non-steroidal anti-inflammatory drugs; PT: physiotherapy. All 
models were adjusted for baseline activity limitations (analysis of covariance). 
*Factor affects the coefficient 10% or more. Reduce patient numbers in the multivariate linear regression analyses due to random data missing in the 
outcome measure or selected variables.
1: Crude Model; 2: Adjusted Model for relevant confounders; 3: Fully Adjusted Model for factors affecting the crude coefficient 10% or more: 
B1Adjusted for CRP change, WOMAC pain change and baseline WOMAC-PF; B2Adjusted for gender, CRP change and baseline GUG test; B3Adjusted 
for baseline stairs test. 
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explained by the important role of muscle function in the knee 
joint. The muscles around the knee control the stop/start of 
the joint motion, add stability and redistribute joint load. In 
addition, appropriate co-contraction of the knee extensor and 
flexor muscles allows the upright position to be maintained, 
compensating for gravity during standing or while performing 
activities (4). Besides the direct association between improve-
ment in muscle strength and decrease in activity limitations, 
which can probably be explained by the participation of 80% of 
the study group in some kind of physical therapy, it is possible 
that indirect pathways may also have influenced this relation-
ship. For example, it is probable that an improvement in muscle 
strength might contribute to an increase in self-confidence, 
resulting in better performance of activities. 
Table V. Association between knee flexor muscle strength change and changes in activity limitations over 2 years
WOMAC-PF score (0–68) GUG test (s) Stairs test (s)
b 95% CI p-value b 95% CI p-value b 95% CI p-value
1 Crude Model
Knee flexor muscle 
strength (FMS) change 




–13.8 –22.3, –5.4 0.001 –1.9 –3.4, –0.4 0.01 –7.4 –10.4, –4.5 < 0.001
FMS change
+ age
–13.6 –21.9, –5.3 0.001 –1.9 –3.4, –0.4 0.01 –7.3 –10.3, –4.4 < 0.001
FMS change
+ BMI change
–13.4 –21.9, –5.0 0.002 –1.9 –3.4, –0.4 0.01 –7.3 –10.3, –4.3 < 0.001
FMS change
+ CRP change
–12.8 –21.2, –4.5 0.003 –1.7* –3.2, 0.2 0.03 –7.1 –10.1, –4.2 < 0.001
FMS change
+ comorbidities change
–14.7 –23.7, –5.8 0.001 –2.0 –3.4, –0.6 0.01 –7.5 –10.8, –4.3 < 0.001
FMS change
+ NSAIDs change
–13.1 –21.3, –4.7 0.003 –1.6* –3.0, –0.1 0.03 –7.3 –10.3, –4.3 < 0.001
FMS change
+ WOMAC pain change
–6.2* –12.3, –0.1 0.05 –1.8 –3.1, –0.5 0.01 –6.6* –9.5, –3.7 < 0.001
FMS change
+ PT treatment
–14.1 –22.8, –5.3 0.002 –1.9 –3.4, –0.3 0.02 –7.2 –10.3, –4.2 < 0.001
3 Fully Adjusted
Model
FMS change –6.2B1 –12.3, –0.1 0.05 –1.4B2 –2.9, 0.01 0.05 –6.6B3 –9.5, –3.7 < 0.001
Linear regression analysis using change in knee flexor muscle strength as independent factor. Changes in WOMAC-PF (Webster Ontario and McMaster 
Osteoarthritis index-Physical Function), Get Up and Go test (GUG), time walking up and down a lap of 12 stairs as dependent variables. b: regression 
coefficient; CI: confidence interval; CRP: C-reactive protein; NSAIDs: non-steroidal anti-inflammatory drugs; PT: physiotherapy. All the models were 
adjusted for the baseline activity limitations (analysis of covariance). 
*Factor affects the coefficient 10% or more. Reduce patient numbers in the multivariate linear regression analyses due to random data missing in the 
outcome measure or selected variables.
1: Crude Model; 2: Adjusted Model for relevant confounders; 3: Fully Adjusted Model for factors affecting the crude coefficient 10% or more: 
B1Adjusted for WOMAC pain change and baseline WOMAC-PF; B2Adjusted for CRP change, NSAIDS change and baseline GUG test; B3Adjusted for 
WOMAC pain change and baseline stairs test. 
Table VI. Association between knee muscle strength change and changes in activity limitations over 2 years (n = 186)
WOMAC-PF score 
(0–68) GUG test (s) Stairs test (s)
b 95% CI p-value b 95% CI p-value b 95% CI p-value
Subjects reporting PT treatment (n = 149)
Knee muscle strength (FMS) change –10.3 –18.1, –2.4 0.011 –1.7 –3.2, –0.4 0.010 –4.4 –6.8, –2.1 < 0.001
Knee extensor muscle strength (FMS) change –6.9 –12.8, –1.1 0.020 –1.0 –2.2, 0.2 0.095 –2.9 –4.6, –1.2 0.001
Knee flexor muscle strength (FMS) change –14.5 –23.8, –5.1 0.003 –2.0 –3.7, –0.3 0.021 –7.1 –10.5, –3.8 < 0.001
Subjects not reporting PT treatment (n = 37)
Knee muscle strength (FMS) change –3.9 –25.7, 17.7 0.714 –1.7 –4.7, 1.2 0.239 –2.9 –8.5, 2.8 0.308
Knee extensor muscle strength (FMS) change –0.9 –14.7, 12.9 0.901 –0.8 –2.7, 1.0 0.396 –1.0 –4.5, 2.6 0.576
Knee flexor muscle strength (FMS) change –10.7 –37.3, 15.8 0.417 –1.2 –5.1, 2.6 0.507 –3.8 –10.9, 3.2 0.278
Linear regression analysis using change in knee muscle strength (KMS) as independent factor. Changes in WOMAC-PF (Webster Ontario and McMaster 
Osteoarthritis index-Physical Function), Get Up and Go test (GUG), time walking up and down a lap of 12 stairs as dependent variables. b: regression 
coefficient; CI: confidence interval; CRP: C-reactive protein; NSAIDs: non-steroidal anti-inflammatory drugs; PT: physiotherapy. All models were 
adjusted for baseline activity limitations (analysis of covariance). 
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The strength of the association between change in muscle 
strength and change in activity limitations was moderate (stairs 
test r = –0.26, p = 0.001 and GUG tests r = –0.23, p = 0.005). 
However, given the small changes in strength and activity 
limitations, the observed association is of considerable interest. 
There was stronger association between change in mean knee 
muscle strength and change in performance-based tests (stairs 
test r = –0.26, p = 0.001 and GUG test r = –0.23, p = 0.005) than 
with changes in self-reported activity limitations (WOMAC-
PF r = –0.16, p = 0.031). This may be due to the influence of 
additional psychosocial factors potentially involved in a self-
reported measure such as WOMAC-PF. Increase in knee exten-
sor muscle strength was associated with better performance on 
the stairs test at 2 years, while increase in knee flexor muscle 
strength was associated not only with better performance tests, 
but also with a decrease in self-reported activity limitations 
at 2-year follow-up. Knee flexor muscles are usually weaker 
than knee extensor muscles (37). This strength imbalance is 
partly due to the larger size of the main knee extensor muscles 
(quadriceps) compared with the main flexors muscles (ham-
strings). Although more attention has commonly been given to 
the assessment of knee extensor muscles due to their leading 
role within activity limitations (38–40), the findings of the 
present study suggest a relevant involvement of knee flexor 
muscles in activity limitations over time in patients with OA, 
highlighting the importance of incorporating training of these 
muscles in intervention programmes.
Study limitations and strengths
Some limitations of this study must be taken into account. First, 
25% of patients dropped out the study at follow-up. However, 
the relevant baseline characteristics were not statistically dif-
ferent between patients who completed and did not complete 
the follow-up assessment (Table I), which makes us believe 
that this loss of patients at follow-up did not impact the results 
of our study. It is possible that the patients who did not attend 
the follow-up assessment might have had a decline in their 
overall condition, including a decrease in muscle strength and 
an increase in activity limitations, which might have prevented 
them from visiting the assessment centre. On the other hand, the 
opposite may also have occurred: patients who experienced an 
improvement in their condition might no longer be interested 
in taking part in the study. The loss of patients may thus have 
caused either an under- or over-estimation of our results. Sec-
ondly, it was not possible to collect exact information about the 
quantity or kind of physical therapy treatment received by the 
patients. This was because the physical therapy reported did not 
necessarily take place at our rehabilitation centre. Therefore, 
only dichotomous information about receiving therapy or not 
(yes/no) was available. 
A significant positive change in muscle strength was ob-
served in the group of patients who received (n = 149) compared 
with the group who did not receive (n = 37) physical therapy 
during the follow-up period (data not shown). However, as 
the group who did not receive physical therapy was very 
small, no separate analyses were presented. Nevertheless, 
this potential confounder was considered in the study, and the 
crude coefficient was not affected after adjusting the model 
for physical therapy treatment. Key strengths of our study are 
the large number of patients with knee OA (n=186) studied 
and a longitudinal design. 
Further research
From a clinical perspective, the results of this study support 
muscle strength training interventions in patients with knee 
OA. Previous intervention studies have found muscle strength 
training interventions to be effective to decrease activity limita-
tions in patients with knee OA (32–36). However, the optimal 
type and amount of exercise to be implemented require further 
definition. In addition, these results highlight the importance 
of training both knee extensor and flexor muscles within the 
intervention programmes. Overall, in patients with OA, opti-
mal delivery of muscle strength training might contribute to a 
decrease in activity limitations and to a subsequent decrease 
in participation restrictions. However, further longitudinal 
observational-studies are needed to test these hypotheses in 
a larger group of patients with established knee OA. We also 
suggest incorporating multiple assessment times over a longer 
follow-up period in order to determine the progression of the 
changes and the associations. 
In conclusion, an increase in knee muscle strength, mainly 
in the knee flexor muscles, was associated with a decrease in 
activity limitation in patients with knee OA after 2 years. These 
results suggest that muscle strength may partially explain the 
between-patient variability in activity limitations over time. 
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